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MiceAbstract Bee products have been used since ancient times to treat many diseases, including respi-
ratory ailments. The present study aimed to examine the modulatory effect of honey, royal jelly,
and propolis extract on peripheral blood leukocytes and lung inﬂammation in a mouse conalbu-
min-induced asthma model. The mice in group I were not sensitised or treated; they were kept as
controls. The mice in group II were sensitised and challenged with conalbumin. Twenty-four hours
after the ﬁrst challenge with antigen, the mice in group III received 0.5 mg/kg of dexamethasone
intraperitoneally per day for 18 consecutive days and kept as positive controls. The mice in groups
IV, V, and VI received 650, 1000, and 30 mg/kg of honey, royal jelly, and propolis (aqueous and
ethanolic extract), respectively, once per day for 18 consecutive days. Blood was collected from
all of the mice for white blood cell differentiation, and the lungs were removed for histopathological
studies. The groups treated with propolis extract exhibited considerable ameliorative effects against
asthma, which might be explained by the ﬂavonoids and phenolics found in propolis, which might
Evaluation of propolis, honey, and royal jelly in peripheral blood leukocytes 781have antioxidative effects. Otherwise, the sensitised and honey- or royal jelly-treated groups exhib-
ited an increased incidence of asthma cascade events due to increased inﬂammatory cells. These
results might be due to the immunostimulatory and vasodilatory effects of royal jelly and honey,
which are antagonistic to bronchial asthma cases. Histopathological examination revealed that
the sensitised treated propolis extract groups had signiﬁcant decreases in inﬂammatory scores com-
pared with other treatments and the sensitised untreated group. These results conﬁrmed the previ-
ous data of peripheral blood cells.
ª 2014 TheAuthors. Production and hosting by Elsevier B.V. on behalf ofKing SaudUniversity. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Honey bees are well known as superior chemists and engineers.
They biochemically synthesised beeswax, venom, and royal
jelly (Bogdanovt, 2014; Viuda-Martos et al., 2008; Mahmoud,
2012), and the successful utilisation of honey bee products has
been described (Schmidt, 1996). The economic importance
and usefulness of honey bees and the therapeutic effects of
their products have motivated scientists to conduct numerous
studies.
Honey and their products have been used since ancient
times as food and medicine to cure many diseases; this practice
is called apitherapy (Manyi-Loh et al., 2011). Honey, propolis,
wax, and other honey bee products were used in combination
with herbs to treat wounds and other diseases by ancient Egyp-
tians, Assyrians, Chinese, Greek, Romans, and Arabians
(Molan, 1999; El Denshary et al., 2012). The use of honey to
cure diarrhoea was recommended by the Muslim Prophet
Muhammad (PBUH) (Molan, 1999), and there is a whole
Surah in the Quran named ‘‘Al-Nahl,’’ describing the life
and beneﬁt of bees. Humans and honey bee use honey as a
source of energy and as a stable sweetener (Manyi-Loh
et al., 2011). The original resins are produced by various types
of plants, collected by honey bees, and converted further into
propolis (Wagh, 2013). Propolis has very good pharmacologi-
cal activities, and it is used as an antimicrobial against
microbes such as viruses, bacteria, fungi, and moulds. It is used
extensively by honey bees to seal the nest cavity and to mum-
mify the cadavers of intruders into the hive that have been
killed (Wagh, 2013). Royal jelly is a complete balanced food
source for bee larvae. It has various properties and is used
by humans not only for moisturising, emulsifying, and stabil-
ising, but also for antitumour and anti-inﬂammatory proper-
ties, antifatigue and hypotensive activity, (Nagai and Inoue,
2004; Inoue et al., 2003), antioxidant activities (Silici et al.,
2009), antibacterial effects (Fujiwara et al., 1990), and
enhancement of immune activity (Sver et al., 1996). With these
unique properties, honey bees have become very important for
human beings (Schmidt, 1996).
Bronchial asthma is considered one of the most chronic dis-
eases affecting children; it is the main cause of children’s
absence from school and for hospital admissions of patients
under 15 years of age (Hockenberry and Wilson, 2007).
Asthma is an inﬂammatory condition characterised by hyper-
sensitivity of the airways, producing symptoms of cough,
especially in the early morning or at night, dyspnoea or expira-
tory wheezing, and chest tightness. The prevalence of asthma,
its complications, and related morbidity and mortality
are increasing worldwide. This increase is attributed to airpollution, poor access to health care services, misdiagnosis,
and mistreatment (Global Strategy for Asthma Management
and Prevention, 2014). According to the World Health Orga-
nisation, the number of asthmatic patients will increase to
100 million by the end of 2025. Currently, allergic asthma is
treated with a standard combined therapy that includes
inhaled corticosteroids and leukotriene receptor antagonists
(Li and Brown, 2009), which lack a consistent cure and pro-
duce side effects (Tinkelman et al., 1993). In recent years,
a new trend of using complementary and alternative medicines
(CAM) has increased worldwide (Barnes et al., 2008).
The CAM includes herbs, acupuncture, Chinese medicine,
and apitherapy. Primary health care for 80% of the world pop-
ulation is dependent on alternative medicine (Barnes et al.,
2008), and using herbs to treat asthma is a popular practice
(Ernst, 1998; Eisenberg et al., 1998). The traditional Chinese
remedy ‘ma huang’, a derivative of herbs and tea leaves, is used
to develop theophylline and ephedrine for asthma drugs
(Ziment, 2000). Lung function has been shown to improve
up to four hours using caffeine, related to theophylline, which
has been used for centuries to treat asthma (Bara and Barley,
2001).
This study was conducted to examine the ameliorating
effect of honey, royal jelly, and propolis on peripheral blood
leukocytes and lung inﬂammation in conalbumin-sensitised
mice.2. Materials and methods
2.1. Animals
Thirty-six albino CD1 mice (male, 6 weeks old, weighing 18–
20 g), obtained from Helwan Breeding Farm, Ministry of
Health, Helwan, Cairo, Egypt, were kept in well-maintained
animal facilities at Biotechnology Research Laboratory, Gas-
troenterology Surgery Centre, Mansoura University, with
proper food and water ad libitum throughout the experiment.
The room was maintained on a 12 h light–dark schedule at a
temperature of 25 ± 2 C and a relative humidity of 58.41–
72.18%. The experiments were performed in accordance with
the guidelines for the use of laboratory animals established
by the Institute of Laboratory Animal Resources Commission
of Life Sciences (1996).
2.2. Honey
One kg of pure, freshly gathered honey was purchased from
Meet El-Aamel apiary, Dakahlyia.
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Freshly gathered honeybee or royal jelly was purchased from
Agricultural Research Centre Station, Tag El-Ezz, Dakahlyia.
2.4. Propolis
Crude propolis was purchased from Agricultural Research
Centre Station, Manzala, Dakahlyia.
2.4.1. Extraction of crude propolis
Propolis was extracted following the protocol developed by
Boeru and Derevici (1978), with slight modiﬁcations. A small
piece of propolis (approximately 50 g) was sliced and squashed
with a mortar and pestle, and the extract was cultured for ten
days in the dark at 45 C with continuous shaking (100 rpm) in
a ﬂask containing ethyl alcohol (95%) at a ratio of 1:5. It was
then ﬁltered through Whatman paper, and the crude extract of
propolis (66.6% concentration) was dried at 60 C. Following
the same technique, aqueous propolis extract was obtained
(36.9 mg/ml) using distilled water in a separate ﬂask; it was
stored at 4 C for further studies.
2.5. Conalbumin sensitisation and induction of lung
inﬂammation
Intraperitoneal injections were administered to the mice for
sensitisation, using 200 lg of conalbumin along with 2 mg of
alum in 0.3 ml of PBS on alternating weeks. The mice were
anesthetised and challenged with conalbumin intratracheally
by aspiration seven days after the last sensitisation (Keane-
Myers et al., 1998; Li et al., 2000). Speciﬁcally, the mice were
placed on a board in a supine position, the tongue was
extended using lined forceps, and conalbumin (100 lg/50 ll
PBS) was applied to the back of the tongue. The intratracheal
challenges were repeated after 20 and 30 days (Group II).
2.6. Treatment of allergic pulmonary inﬂammation
The animals were divided into six groups (six mice in each
group). The mice in group I were not sensitised or treated; they
were kept as controls. The mice in group II were sensitised and
challenged with conalbumin as mentioned previously. Twenty-
four hours after the ﬁrst antigen challenge, the mice in group
III received 0.5 mg/kg of dexamethasone intraperitoneally
once per day for 18 consecutive days, and they were kept as
a positive control. The mice in groups IV, V, and VI received
650, 1000, and 30 mg/kg honey (Ali et al., 1997), royal jelly
(Fujii et al., 1990), and propolis (aqueous and ethanolic
extract), respectively (Campos et al., 1998), once per day for
18 consecutive days.
Peripheral blood was collected from the caudal vein of all
the animals 24 h after the ﬁnal treatment dose. Blood smears
were made immediately, following routine procedures, and
stained with Leishman’s stain for white blood cell differentia-
tion. The lungs were removed immediately after administering
a formalin injection via the trachea to evacuate air from the
alveoli, and they were preserved in 10% formalin for histopa-
thological studies.2.7. Peripheral white blood count
The blood smears were ﬁxed with absolute methanol and
stained with Leishman’s stain for white blood cell differentia-
tion. Approximately 300 inﬂammatory cells counted by two
researchers using a light microscope were subsequently classi-
ﬁed as neutrophils, monocytes, lymphocytes, eosinophils, and
basophils (Chang et al., 2004).
2.8. Histopathological examination
The formalin-infused lungs were embedded in parafﬁn wax
blocks and sliced into 6 lm-thick sections. The slides were
examined under a light microscope after staining with haema-
toxylin and eosin. The scoring of the airway inﬂammation was
blindly investigated by two separate investigators. A standard
scale (0–3) was used to evaluate the severity of perivascular
and peribronchial inﬂammation (Park et al., 2001) and to
assign value: 0 for no evident inﬂammation, 1+ for foci or
infrequent cufﬁng with inﬂammatory cells, 2+ if most bronchi
or vessels were surrounded by a thin layer, and 3+ for the
most severe inﬂammation (more than ﬁve cells deep) of inﬂam-
matory cells. The average of the peribronchial and perivascular
inﬂammation scores was used to deﬁne total lung
inﬂammation.
2.9. Statistical analysis
Statistical Package for the Social Sciences (ªSPSS Inc. 1989–
1999, Chicago, IL, USA) was used for statistical analyses.
The test of normal distribution by the Kolmogorov–Smirnov
test was used to determine parametric and nonparametric data.
The parametric data were analysed by a one-way ANOVA test
used for analysis of variance within and between the groups.
The least signiﬁcance difference test was used as a post hoc
test for multiple comparisons between the tested groups
after the analysis of variance. For nonparametric data of cat-
egorical variables, comparisons were carried out by Chi-square
(v2) test. The inﬂammatory score data were expressed as
means ± standard deviation. The signiﬁcant statistical differ-
ence was accepted at p< 0.05, and all p-values reported are
double-sided (two-tailed distributions).
3. Results
3.1. Haematological studies
Examination of the blood smears showed signiﬁcant differ-
ences in the differential peripheral blood counts of the different
animal groups. As shown in Fig. 1, the percentages of periph-
eral blood neutrophils were signiﬁcantly higher in the dexa-
methasone-treated group (48.33%) than in the other groups.
Thus, dexamethasone had the best results as a standard corti-
costeroid drug. The other groups, with naı¨ve and sensitised
non-treated animals, exhibited insigniﬁcant differences in neu-
trophil percentages, but there were signiﬁcant increases in the
royal jelly treated group and signiﬁcant decreases in the dexa-
methasone, sensitised honey, and sensitised royal jelly treated
groups (Figs. 2 and 3).
Figure 1 The percentage of peripheral blood neutrophils in normal control, cone albumin sensitised, dexamethasone, water and ethanol
propolis extract, ethanol, honey and royal jelly sensitised and treated groups.
Figure 2 The percentage of peripheral blood lymphocytes in normal control, cone albumin sensitised, dexamethasone, water and ethanol
propolis extract, ethanol, honey and royal jelly sensitised and treated groups.
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count in the sensitised untreated group (6.0%), which is an
indicator of successful asthma inducing. The same was
observed for the sensitised honey treated group (6.3%). There
was a signiﬁcant increase in the percentage of eosinophils in
the sensitised group (asthmatic mice) compared to the naı¨ve
one. On the contrary, there were signiﬁcant increases in the
ethanol, honey, and royal jelly -treated groups compared with
the naı¨ve group (6.0%, 5.6%, and 6.66%, respectively), and
insigniﬁcant differences in the sensitised untreated group.
These increases might be due to the immunostimulatory char-
acteristics of honey, and royal jelly (Fig. 4).Fig. 5 illustrates the basophil percentages of the different
animal groups. The highest level was recorded in the sensitised
group (6.0%) compared to the naı¨ve group (3.5%). There was
a signiﬁcant decrease in the dexamethasone treated group
(1.67%) compared to the sensitised untreated group. The other
groups showed insigniﬁcant differences compared with the
naı¨ve group, with the exception of the honey (5.5%) and royal
jelly (5.0%) treated groups, which increased signiﬁcantly com-
pared with the naı¨ve group, but which differed insigniﬁcantly
from the sensitised untreated group.
The groups treated with propolis extracts exhibited consid-
erable ameliorative effects against asthma. Propolis has
Figure 3 The percentage of peripheral blood monocytes in normal control, cone albumin sensitised, dexamethasone, water and ethanol
propolis extract, ethanol, honey and royal jelly sensitised and treated groups.
Figure 4 The percentage of peripheral blood eosinophils in normal control, cone albumin sensitised, dexamethasone, water and ethanol
propolis extract, ethanol, honey and royal jelly sensitised and treated groups.
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effects, thus explaining that result. Otherwise, the sensitised
and honey or royal jelly treated groups showed an increase
in asthma cascade events by increasing the inﬂammatory cells.
These results might be due to the immunostimulatory and
vasodilatory effects of royal jelly and honey, which are antag-
onistic to bronchial asthma cases.
3.2. Histopathological examination
The normal lungs of the naı¨ve mice revealed an intact bronchi-
olar structure of a pseudostratiﬁed epithelial layer lining the
bronchi and bronchioles, normal alveoli, and normal blood
vessels (Fig. 6a). Histopathological examination of the pul-
monary tissue included the deﬁnition of peribronchial and per-
ivascular inﬂammatory cell scores. The inﬂammatory cells,including eosinophils, monocytes, neutrophils, and lympho-
cytes are one of the allergic asthma indicators. The score of
inﬂammation was considered 1+ if the inﬂammatory cells
were occasional (Fig. 6b), 2+ if they were all-around peribron-
chial or perivascular and less than ﬁve layers deep (Fig. 6c),
and 3+ if all-around inﬂammation with more than ﬁve layers
(Fig. 6d).
Some of the asthma histopathological ﬁndings were
observed as shedding or oedema of some epithelial cells in
focal cases (Fig. 6b). The dilation of alveoli in focal or mild
cases is one of the common ﬁndings in asthmatics, as the alve-
oli become ﬁlled with air as a result of airways constriction
(Fig. 6c). In severe cases, there is emphysema, in which the
alveoli burst and are confused with each other due to their
hyperinﬂation with air, which is an irreversible complication
of airways constriction (Fig. 6d). The inﬂammatory cell scores
Figure 5 The percentage of peripheral blood basophils in normal control, cone albumin sensitised, dexamethasone, water and ethanol
propolis extract, ethanol, honey and royal jelly sensitised and treated groups.
Figure 6 Light photomicrographs of sections in lungs of different animal groups showing control for different degrees of asthma (H &
E). (A) Normal small bronchus (BR) without detectable inﬂammatory reaction showing intact epithelium (E), blood vessel (BV) and
alveoli (AV). (B) Focal perivascular inﬂammatory cells (arrow head) around small bronchus (BR). Slight oedema appears in epithelial
layer (E) and inﬂation of alveoli (AV) in mild asthma. (C) All-around peribronchial (BR) and perivascular (BV) inﬂammation (arrow
heads) forming less than 5 cell-deep layers with more oedematous epithelium (E) and inﬂation of alveoli (AV) in mild persistent asthmatic
mice. (D) All-around peribronchial (BR) and perivascular (BV) inﬂammation (arrow heads) forming more than 5 cells-deep layers with
inﬂated alveoli (AV) and burst fused others forming emphysema (EP) in severe asthmatic cases.
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tised treated propolis extract groups showed greater signiﬁcant
decreases in inﬂammatory scores than the other treatment groups
compared with the sensitised untreated group. These results are in
agreement with the previous data of peripheral blood cells.4. Discussion
Lung function can potentially be affected in many patients by
chronic inﬂammatory disorders, ﬁnally resulting in asthma.
Due to interaction of inﬂammatory cells with resident cells,
Table 1 Histopathological examination of lung tissues in normal control, cone albumin sensitised, dexamethasone, water and ethanol
propolis extract, honey and Royal Jelly sensitised and treated groups and their statistical differences using Chi-square (v2) test.
N S DEX SAPE SE SEPE SH SRJ
1+ 2 1 2 2 1 1 0 0
2+ 1 0 1 1 2 2 0 2
3+ 0 2 0 0 0 0 3 1
P <0.05 <0.05 <0.05 <0.05 <0.05
S a b b b b a a
N=Naive, S = Sensitised, DEX= Dexamethasone, SAPE = Sensitised water propolis extract, SE = Sensitised ethanol, SEPE= Sensitised
ethanolic propolis extract, SH = Sensitised honey, SRJ = Sensitized royal jelly.
1+= focal inﬂammation.
2+= all around inﬂammation (<5 layers cells deep).
3+= all around inﬂammation (>5 layers cells deep).
P= probability.
S= signiﬁcance.
a= signiﬁcant increase in inﬂammatory cells comparable to the naive group.
b= signiﬁcant decrease in inﬂammatory cells comparable to the sensitised group.
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asthmatic inﬂammation develops. The clinical manifestations
include bronchial epithelial damage, airway smooth muscle
spasm, airway mucus secretion, further inﬂammation, and air-
way oedema and narrowing (Lemanske, 2000). Animal mod-
els, including mice, are used extensively in the study of
allergic disease mechanisms because of their silent features of
allergic airway inﬂammation in humans and other properties
such as low cost and a well-known immune system. Conalbu-
min is a known aeroallergen that is used as a successful asthma
inducer. The sensitised non-treated group of mice in this study
exhibited signiﬁcantly increased peripheral blood eosinophils
and basophils. However, lymphocytes, monocytes, and neutro-
phils decreased in the sensitised group compared with the naı¨ve
(non-sensitised) group. This result indicates successful sensiti-
sation and development of an allergic model. Peripheral blood
eosinophilia has been documented in bronchial asthma in both
human (Simon, 2013) and murine (Nakashima et al., 2014)
models.
In this work, a signiﬁcant increase in the number of inﬂam-
matory cells invading the lungs in the sensitised non-treated
group, compared to the control group, was observed. This
ﬁnding is in agreement with some previous studies that
revealed invasion of the lung tissues by eosinophils, lympho-
cytes, neutrophils, and monocytes after sensitisation in murine
models of atopic asthma (Blyth et al., 1996; Kumar et al.,
2003). That work showed that the dexamethasone-treated
group exhibited a signiﬁcant reduction in percentage of circu-
lating eosinophils compared to the sensitised non-treated
group, and an insigniﬁcant increase compared to the control
group. Dexamethasone is a golden drug in bronchial asthma
treatment. It suppresses Th2, which leads to a decline in the
percentage of eosinophils and basophils, hence releasing the
ability of Th1 (which was suppressed by the dominance of
Th2 due to asthma) to express their cytokines. In turn, these
cytokines elevate the percentage of neutrophils, monocytes,
and lymphocytes (autocrine). The reduction of inﬂammatory
cells in the circulation system and in tissues by systemically
administered corticosteroids has been reported in allergic mur-
ine asthma models (De Bie et al., 1996; Triﬁlieff et al., 2000). In
that work, sensitised aqueous propolis extract and sensitisedethanolic propolis extract treated groups exhibited signiﬁcant
increases in the percentage of peripheral blood neutrophils,
lymphocytes, and monocytes.
The effect of propolis extract was evaluated previously and
found to be a better therapeutic and immunomodulatory agent
for asthma (Araujo et al., 2012). In that work, the sensitised
and honey treated group showed a signiﬁcant decrease in
Th1-mediated cells (neutrophils, lymphocytes, and monocytes)
and a signiﬁcant increase in Th2-mediated cells (eosinophiles
and basophiles) in peripheral blood and lung tissues than in
the naı¨ve group. Honey is known as a wound-healing and tis-
sue-repairing agent that acts by stimulating the inﬂammatory
cytokines from monocytic cells (Tonks et al., 2003). These
characteristics may stimulate inﬂammatory cell proliferation,
which might explain the increasing cascade of events of bron-
chial asthma disease. In this study, administration of royal jelly
at a dose of 1 g/kg/day resulted in a signiﬁcant increase in
peripheral blood eosinophilia and lung inﬂammatory cell accu-
mulation compared with the control (naı¨ve) group. At the
same time, there were insigniﬁcant differences between this
group and the sensitised untreated group. Similarly, increased
atopic manifestations were observed in a study on royal jelly
consumption in Hong Kong (Leung et al., 1997). The lipid per-
oxidation model was used to evaluate the antioxidative effects
of honeys, royal jelly, and propolis (Nagai et al., 2001). Their
superoxide-scavenging activities, arranged in a decreasing
manner, are propolis > royal jelly > honey; these ﬁndings
greatly support the results of the current study.5. Conclusion
The percentage of circulating and lung-inﬁltrated eosinophils
and basophils decreased signiﬁcantly in the sensitised and
propolis extract treated groups. In addition, the percentages
were still insigniﬁcantly higher than those of the naı¨ve and
dexamethasone-treated groups. These ﬁndings support the
hypothesis that propolis extracts may have an anti-inﬂamma-
tory role, and hence, ameliorative effects in allergic asthma
by free radical scavenging. Indeed, there is a need for new or
alternative approaches to the control of this disease.
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